GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biophytis SA (FRA:6XB3) » Definitions » Market Cap

Biophytis (FRA:6XB3) Market Cap : €2.29 Mil (As of Dec. 12, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Biophytis Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Biophytis's share price for the quarter that ended in Jun. 2024 was €0.57. Biophytis's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 5.24 Mil. Therefore, Biophytis's market cap for the quarter that ended in Jun. 2024 was €2.99 Mil.

Biophytis's quarterly market cap declined from Jun. 2023 (€7.47 Mil) to Dec. 2023 (€3.64 Mil) and declined from Dec. 2023 (€3.64 Mil) to Jun. 2024 (€2.99 Mil).

Biophytis's annual market cap declined from Dec. 2021 (€66.53 Mil) to Dec. 2022 (€9.53 Mil) and declined from Dec. 2022 (€9.53 Mil) to Dec. 2023 (€3.64 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Biophytis's Enterprise Value for Today is €7.18 Mil.


Biophytis Market Cap Historical Data

The historical data trend for Biophytis's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biophytis Market Cap Chart

Biophytis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.55 78.79 66.53 9.53 3.64

Biophytis Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.73 9.53 7.47 3.64 2.99

Competitive Comparison of Biophytis's Market Cap

For the Biotechnology subindustry, Biophytis's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biophytis's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biophytis's Market Cap distribution charts can be found below:

* The bar in red indicates where Biophytis's Market Cap falls into.



Biophytis Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Biophytis's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€1.4*2.60121
=€3.64

Biophytis's Market Cap for the quarter that ended in Jun. 2024 is calculated as

Market Cap (Q: Jun. 2024 )=Share Price (Q: Jun. 2024 )*Shares Outstanding (EOP) (Q: Jun. 2024 )
=€0.57*5.24165
=€2.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biophytis  (FRA:6XB3) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Biophytis Market Cap Related Terms

Thank you for viewing the detailed overview of Biophytis's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Biophytis Business Description

Traded in Other Exchanges
Address
BC 9, Batiment A 4eme etage, 4 pace Jussieu, Sorbonne University, Paris, FRA, 75005
Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Its drug candidate BIO101, is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and DMD.

Biophytis Headlines

No Headlines